Literature DB >> 2876489

The effect of gentamicin on human renal proximal tubular cells.

A L Regec, A L Trifillis, B F Trump.   

Abstract

Human renal proximal tubular cells were exposed to gentamicin (0, 0.1, 0.5, 1.0, 5.0, 10.0 mg/ml medium) for 3, 7, 10, and 14 days. Cells were counted and cell viability was estimated by lactate dehydrogenase release. In addition, brush border-associated (gamma-glutamyltransferase) and lysosomal (acid phosphatase, N-acetyl-beta-glucosaminidase, and sphingomyelinase) enzyme activities were measured (0.01, 1.0, 3.3 mg/ml gentamicin for 3, 7, 10 and 14 days). The number of cells did not change significantly after gentamicin treatment. Cell viability, however, significantly decreased after 3 and 7 days exposure to 5 and 10 mg/ml gentamicin. Total lactate dehydrogenase activity was significantly decreased at 7, 10, and 14 days exposure to gentamicin greater than or equal to 5.0 mg/ml. gamma-Glutamyltransferase, acid phosphatase, and sphingomyelinase were decreased at 3, 7, and 10 days exposure to gentamicin greater than or equal to 1.0 mg/ml. Continued exposure to gentamicin less than or equal to 1.0 mg/ml appeared to have little or no effect on the activity of these enzymes at 14 days. N-Acetyl-beta-glucosaminidase activity, in contrast, was elevated (120-140% control) in the gentamicin-treated (greater than or equal to 1.0 mg/ml) groups at all time periods studied. Thus, gentamicin exposure resulted in changes in some of the enzyme activities in human renal proximal tubular cell cultures, but longer exposure (14 days) to gentamicin (less than or equal to 1.0 mg/ml) resulted in a return to control levels of some activities.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876489     DOI: 10.1177/019262338601400213

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  5 in total

1.  Use of human renal proximal tubule cell cultures for studying foscarnet-induced nephrotoxicity in vitro.

Authors:  A L Trifillis; X Cui; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

2.  Urinary excretion of beta-2-microglobulin in patients with active metabolic stone disease.

Authors:  D Musialik
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

3.  Human proximal tubule cells form functional microtissues.

Authors:  Jenny A Prange; Manuela Bieri; Stephan Segerer; Charlotte Burger; Andres Kaech; Wolfgang Moritz; Olivier Devuyst
Journal:  Pflugers Arch       Date:  2015-12-17       Impact factor: 3.657

4.  Human iPSC-derived renal organoids engineered to report oxidative stress can predict drug-induced toxicity.

Authors:  M L Lawrence; M Elhendawi; M Morlock; W Liu; S Liu; A Palakkan; L F Seidl; P Hohenstein; A K Sjögren; J A Davies
Journal:  iScience       Date:  2022-02-07

5.  HiPSC-Derived Hepatocyte-like Cells Can Be Used as a Model for Transcriptomics-Based Study of Chemical Toxicity.

Authors:  Sreya Ghosh; Jonathan De Smedt; Tine Tricot; Susana Proença; Manoj Kumar; Fatemeharefeh Nami; Thomas Vanwelden; Niels Vidal; Paul Jennings; Nynke I Kramer; Catherine M Verfaillie
Journal:  Toxics       Date:  2021-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.